Zusammensetzungen und Verfahren zur Behandlung von Epithel- und Retinagewebeerkrankungen

• 收藏
• 分享

专利权人:

Inspire Pharmaceuticals; Inc.

发明人:

申请号：

EP13002486.2

公开号：

EP2647382A1

申请日:

2003.02.27

申请国别(地区):

EP

年份:

2013

代理人:

摘要：

The present invention relates to mononucleoside phosphate compounds that have the benefits of a dinucleotide pharmaceutical. These mononucleoside phosphates can be made from a mononucleotide that has been modified by attaching a degradation resistant substituent on the terminal phosphate of a polyphosphate mononucleotide. By attaching this degradation resistant substituent, the stability from degradation matches or exceeds those of certain dinucleotides.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/